Topical imiquimod 5% cream in external anogenital warts: A randomized, double-blind, placebo-controlled study

Journal of Dermatology

Volumn 31, Issue 8, 2004, Pages 627-631

  Arican, Ozer ^a,d   Guneri, Funda ^b   Bilgic, Kaan ^c   Karaoglu, Aynur ^b  

^a KAHRAMANMARAS SUTCU IMAM UNIVERSITY   (Turkey)

^b Haseki State Hospital   (Turkey)

^c Boyabat Hospital   (Turkey)

^d NONE   (Turkey)

Author keywords

Anogenital warts; Human papillomaviruses; Imiquimod; Treatment

Indexed keywords

IMIQUIMOD;

ANOGENITAL WART; ANUS; ARTICLE; BURNING SENSATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONDYLOMA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; DRUG SAFETY; EROSION; ERYTHEMA; EXCORIATION; FEMALE; FLU LIKE SYNDROME; HUMAN; MALE; PATIENT MONITORING; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SIDE EFFECT; VOLUNTEER;

EID: 4544356741     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2004.tb00568.x     Document Type: Article

References (18)

1. Koutsky L: Epidemiology of genital human papillomavirus infection, Am J Med, 102: 3-8, 1997.
2. Beutner KR, Ferenczy A: Therapeutic approaches to genital warts, Am J Med, 102: 28-37, 1997.
3. Stone KM: Human papillomavirus infection and genital warts: Update on epidemiology and treatment, Clin Infect Dis, 20 (Suppl): 91-97, 1995.
4. Coleman N, Birley HDL, Renton AM, et al: Immunological events in regressing genital warts, Am J Clin Pathol, 102: 768-774, 1994.
5. Friedman-Kien AE, Eron LJ, Conant M, et al: Natural Interferon alfa for treatment of condylomata acuminata, JAMA, 259: 533-538, 1988.
6. Eron LJ, Judson F, Tucker S, et al: Interferon therapy for condylomata acuminata, N Eng J Med, 315: 1059-1064, 1986.
7. Weeks CE, Gibson SJ, Imbertson LM: Preclinical pharmacology and efficacy of immunomodulator candidate R-837, J Interferon Res, 9 (Suppl 1): 89, 1989.
8. Harrison JC, Jenski L, Miller RL, Bernstein DI: Treatment of genital HSV2 with R-837, Antivir Res, 9: 125, 1988.
9. Sidky YA, Bryan GT, Weeks CE, Hatcher JM, Borden EC: Effects of treatment with an oral interferon inducer, imidazoquinolinamine (R-837), on the growth of mouse bladder carcinoma FBC, J Interferon Res, 10 (Suppl 1): 123, 1990.
10. Sauder DN: Effects of a novel topical immunomodulator, imiquimod on keratinocyte cytokine gene expression, Lymphokine Cytokine Res, 13: 71-76, 1994.
11. Tyring SK, Arany I, Stanley MA, et al: A Randomized, controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod, J Infec Dis, 178: 551-555, 1998.
12. Wick KA, Kwam DC, Weeks CE, et al: Oral R-837 induces Interferon in healthy volunteers. Proc Am Assoc Cancer Res, 32: 257, 1991.
13. Beutner KR, Geisse JK: Imiquimod-an immune response modifier for the treatment of genital warts, Today's Therapeutic Trends, 15: 165-178, 1997.
14. Beutner KR, Spruance SL, Hougham AJ, Fox TL, Owens ML, Douglas JM Jr: Treatment of genital warts with an immune-response modifier (imiquimod), J Am Acad Dermatol, 38: 230-239, 1998.
15. Edwards L, Ferenczy A, Eron L, et al: Self-administered topical 5% imiquimod cream for external anogenital warts, Arch Dermatol, 134: 25-30, 1998.
16. Skinner RB Jr: Imiquimod, Dermatol Clin, 21: 291-300, 2003.
17. Edwards L: Imiquimod in clinical practice, J Am Acad Dermatol, 43 (Suppl): 12-17, 2000.
18. Beutner KR, Tyring SK, Trofatter KF Jr, et al: Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts, Antimicrob Agents Chemother, 42: 789-794, 1998.